Japanese Metals and Mining Stock News

Board meeting puts Kanadevia’s group structure in focus Kanadevia (TSE:7004) has called a board meeting for March 26, 2026, to review and approve a potential share transfer involving a consolidated subsidiary, bringing attention to how any change might affect the wider group. See our latest analysis for Kanadevia. The upcoming board meeting lands after a mixed period for the stock, with a 7.92% year to date share price return and a 10.11% one year total shareholder return suggesting that...

Amidst a backdrop of geopolitical tensions and fluctuating energy prices, Asian markets are navigating a complex landscape that influences investor sentiment. In this environment, dividend stocks can offer stability and potential income, making them an attractive option for those seeking to balance risk with consistent returns.

Trend Micro (TSE:4704) is back in focus after unveiling its TrendAI Agentic Governance Gateway, a product aimed at securing autonomous AI agents across complex workflows, following research that underscores rising AI adoption despite unresolved risk controls. See our latest analysis for Trend Micro. The new AI security launches sit against mixed recent trading, with the share price at ¥5,338 after a 2.32% 1 day share price return, a 21.11% 90 day share price decline, and a 46.82% 1 year total...

Daiichi Sankyo Company (TSE:4568) shares are in focus after a new collaboration with Tempus AI to apply foundation models and real-world oncology data to an antibody drug conjugate program. See our latest analysis for Daiichi Sankyo Company. The AI collaborations, ENHERTU approval in Japan and completion of the latest buyback tranche come as the share price trades at ¥2,930 following a 1 day share price return of 1.93%. However, the 1 year total shareholder return of 19.20% and 3 year total...

Takeda Pharmaceutical (TSE:4502) is back in focus after releasing new Phase 3 data for its investigational TYK2 inhibitor zasocitinib in moderate to severe plaque psoriasis, paired with plans for future regulatory filings. See our latest analysis for Takeda Pharmaceutical. The zasocitinib data appear to have arrived during a strong run for the shares, with a 90-day share price return of 19.92% and a 1-year total shareholder return of 33.75% suggesting momentum has been building over both...

Sojitz group company Royal Healthcare in Singapore has begun offering NEC Corporation's FonesVisuas Test, an advanced blood test that estimates the risk of multiple diseases. This marks Sojitz's entry into predictive health testing in Southeast Asia through its partnership with NEC and Royal Healthcare. The move expands Sojitz's presence in healthcare, adding a new dimension to its business portfolio in the Asia Pacific region. For investors tracking Sojitz (TSE:2768), this development adds...

Elliott Investment Management’s new statement on Mitsui O.S.K. Lines (TSE:9104) has pushed investor attention toward the company’s upcoming medium term management plan and the question of how the market values its shipping assets. See our latest analysis for Mitsui O.S.K. Lines. The Elliott statement lands after a strong run in the share price, with a 30 day share price return of 23.39% and a 90 day share price return of 51.93%. The 5 year total shareholder return of roughly 7x signals that...

Why Tokyo Electron Is On Investors’ Radar Now Tokyo Electron (TSE:8035) has drawn attention after a sharp month pullback of about 13%, even as its past 3 months return sits around 14%. That gap is prompting closer scrutiny from investors. See our latest analysis for Tokyo Electron. The recent 13% one-month share price pullback to about ¥39,290 comes after a 14% three-month share price return and a very strong one-year total shareholder return of 84%. This suggests that short-term momentum has...

Mitsubishi Electric, Toshiba and Rohm are reported to be in talks to merge their power semiconductor device operations. The potential combination would create a larger Japanese player in power chips, an area supported by government policy and global demand trends. The development is seen as a material shift for Mitsubishi Electric’s power device business and its competitive position in TSE:6503. Mitsubishi Electric, listed as TSE:6503, is entering these merger talks with a share price of...

Wondering whether Nintendo's share price reflects its true value today, or if the market is missing something that you could be early to? The stock recently closed at ¥9,215, with a 5.5% gain over the last 30 days, although returns sit at a 13.5% decline year to date and a 14.7% decline over the last year, set against an 87.7% gain over 3 years and 63.7% over 5 years. Recent coverage has focused on how Nintendo fits into the broader entertainment and gaming sector, including discussion of...

Investors in Kao Corporation ( TSE:4452 ) had a good week, as its shares rose 2.2% to close at JP¥6,147 following the...

On March 18, 2026, Toho Co., Ltd.’s board approved sweeping leadership changes, including Representative Director Yoshishige Shimatani stepping down to become Corporate Adviser and the planned retirement of several senior Executive Officers across its real estate, theatrical, and cinema businesses. These shifts reshuffle decision‑making power across Toho’s core operating groups, potentially signaling an internal rethink of how its film, theater, and property operations are led. With these...

SoftBank Group (TSE:9984) has secured a $40b unsecured bridge loan underwritten by major global banks. The facility is intended to finance a planned $30b follow on investment in OpenAI. The move deepens SoftBank's alignment with OpenAI across AI hardware and software, including links to Arm Holdings. For you as an investor, this is a large capital commitment that puts SoftBank Group in a central position in the current AI cycle. The planned follow on stake in OpenAI connects directly with...

Rohto PharmaceuticalLtd (TSE:4527) has announced a share repurchase program, authorizing the buyback of up to 1,500,000 shares for ¥3,000 million. The initiative is intended to improve capital efficiency and support flexible capital policies. See our latest analysis for Rohto PharmaceuticalLtd. At a share price of ¥2,412.0, Rohto PharmaceuticalLtd has a 7 day share price return of 2.14% and a 1 year total shareholder return of 6.88%. The 3 year total shareholder return of 10.34% contrasts...

Recent share performance context Kioxia Holdings (TSE:285A) has drawn attention after a sharp share price swing, with the stock showing a 4.2% decline over the past day and a 9.3% drop over the past week. See our latest analysis for Kioxia Holdings. Despite the recent pullback, with a 5.6% 1 month share price return decline, Kioxia Holdings still shows strong momentum when viewed over the year, highlighted by a 77.6% 3 month share price return and a very large 1 year total shareholder...

Event context and recent share performance Honda Motor (TSE:7267) has been drawing attention after recent share price swings, with the stock up around 1.5% over the past day but showing weaker performance over the past month and past 3 months. For investors, that mix of short term strength and recent declines raises questions about how current expectations around earnings, cash flows, and long term demand for Honda’s automobiles, motorcycles, and power products are being reflected in the...

Hokuriku Electric Power (TSE:9505) cut its profit outlook for the year ending March 31, 2026, after deciding to abolish the Fukui Thermal Power Station Mikuni Unit 1 and recognize related impairment losses. See our latest analysis for Hokuriku Electric Power. The board’s decision on Mikuni Unit 1 and the resulting downgrade to profit guidance comes against a backdrop of a 13.31% 90 day share price return and a 94.79% 3 year total shareholder return. This suggests recent momentum has built on...

Ono Pharmaceutical has submitted a manufacturing and marketing application in Japan for ripretinib, an oral tyrosine kinase inhibitor for advanced gastrointestinal stromal tumor that has progressed after prior chemotherapy, supported by positive global Phase 3 INVICTUS data showing significantly prolonged progression-free survival versus placebo. The filing is reinforced by ripretinib’s orphan drug status and its designation as a high medical-need therapy in Japan, highlighting its potential...

Investors may be wondering if ASICS at ¥4,306 is still offering value after its strong run, or if most of the easy gains are now behind it. The share price shows a mix of short term pressure and longer term strength, with a 2.2% decline over 7 days and a 7.8% decline over 30 days, set against an 11.9% gain year to date and a 35.9% return over the last year. Over a multi year horizon the stock has delivered very large returns, with the 3 year performance and the 5 year performance each...

Wondering if Sumitomo Mitsui Financial Group's current share price reflects its true worth, or if the market is mispricing this major Japanese bank. The stock closed at JP¥5,246 recently, with a 1.7% gain over the last 7 days, a 7.9% decline over 30 days, and returns of 1.2% year to date and 35.8% over the past year, while the 3 year and 5 year returns stand at 223.9% and 384.4% respectively. Recent coverage around large Japanese banks has focused on how investors are reassessing financial...

If you are wondering whether Daiichi Sankyo Company is attractively priced or simply reflecting its risks, the recent share performance provides a useful starting point before assessing valuation. The stock last closed at ¥2,930, with a 0.9% gain over the past week, a 2.2% decline over 30 days, and year-to-date and 1-year returns of 17.0% and 19.2% declines respectively, as well as a 37.0% decline over 3 years and a 0.7% decline over 5 years. Recent coverage around Daiichi Sankyo has focused...

Earlier this week, Formentera Partners and INPEX announced a joint venture to accelerate development of onshore natural gas resources in Australia’s Beetaloo Basin, with INPEX gaining acreage through a staged earn-in to support domestic supply and potential LNG exports. This partnership combines Formentera’s shale development capabilities with INPEX’s LNG project experience, potentially creating a new, scalable gas hub that could influence the company’s long-term resource mix and...

Why Sumitomo (TSE:8053) Is On Investors’ Radar Today Sumitomo (TSE:8053) has drawn fresh attention after recent share price moves, with the stock up 1.8% over the past day and 5.1% over the past week, while showing mixed month and past 3 months performance. See our latest analysis for Sumitomo. At the current share price of ¥5,991.0, Sumitomo’s recent strength, with a 7.6% year to date share price return and 72.2% 1 year total shareholder return, points to momentum that contrasts with its...

Investors in Unicharm Corporation ( TSE:8113 ) had a good week, as its shares rose 2.8% to close at JP¥945 following...